Oncology
Qilu Pharmaceutical Co. Ltd. is active in non-small cell lung cancer research, with clinical interest centered on adjuvant therapy and immuno-oncology treatment development. The sponsor’s work in this area includes evaluation of pharmacokinetics and pharmacodynamics for oncology-focused candidates.
- Non-small cell lung cancer
- Adjuvant therapy
- Immuno-oncology
- Pharmacokinetics
Its oncology portfolio reflects interest in therapies used to support cancer treatment and in the characterization of biologic agents relevant to PD-1/PD-L1-linked pathways.
Hematology
The sponsor also funds research in immune thrombocytopenia, indicating a therapeutic focus on platelet disorders and immune-mediated blood conditions. This area aligns with clinical development activities aimed at improving treatment options for hematologic disease.
- Immune thrombocytopenia
- Platelet disorders
- Immune-mediated hematologic disease
Clinical activity in this field points to interest in therapies that address abnormal platelet destruction and related hematologic complications.
Radiation Injury and Emergency Medicine
Qilu Pharmaceutical Co. Ltd. includes hematopoietic syndrome of acute radiation syndrome among the conditions under study, showing involvement in radiation injury and supportive care research. This domain is associated with restoration of blood-forming capacity after radiation exposure.
- Hematopoietic syndrome of acute radiation syndrome
- Radiation injury
- Hematopoietic recovery
The sponsor’s interest in this area connects to medical needs in radiological emergencies and treatment of severe marrow suppression.
Biologic Therapeutics Characterization
Its clinical research also covers comparative assessment of biologic candidates through pharmacokinetic and pharmacodynamic evaluation. This indicates a focus on biologic therapy development and the clinical characterization of agents used in oncology and immune-related disease.
- Pharmacokinetic similarity
- Pharmacodynamic assessment
- Biologic therapy
These activities support research into treatment behavior in the body and biological activity across therapeutic areas.
